Alkermes Plc

Stock Chart, Company Information, and Scan Results

$27.85(as of Sep 9, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Alkermes Plc Company Information, Fundamentals, and Technical Indicators

Stock Price$27.85
Ticker SymbolALKS
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,800
CountyUSA
Market Cap$4,942.4M
EBIDTA403.3M
10-Day Moving Average29.18
P/E Ratio13.75
20-Day Moving Average28.82
Forward P/E Ratio17.83
50-Day Moving Average28.34
Earnings per Share2.07
200-Day Moving Average30.26
Profit Margin22.30%
RSI48.36
Shares Outstanding165.1M
ATR1.21
52-Week High36.45
Volume5,511,323
52-Week Low25.17
Most Recent Support Level28.77
Book Value1,624.6M
Most Recent Resistance Level30.24
P/B Ratio2.95
Upper Keltner31.54
P/S Ratio3.18
Lower Keltner26.11
Debt-to-Equity Ratio31.54
Next Earnings Date10/23/2025
Cash Surplus15.2M
Next Ex-Dividend DateUnknown

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Alkermes Plc In Our Stock Scanner

As of Sep 09, 2025
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.